Highly trained neurologists at Riley Children’s Health use the latest tools and therapies to diagnose and treat the most complex neurologic disorders in children. Our team manages numerous specialized multidisciplinary services, including programs for muscular dystrophy and refractory epilepsy. NEUROLOGY
RESEARCH HIGHLIGHTS
Riley neurologists are engaged in clinical research related to the following: ■ Myostatin inhibitors for spinal muscular atrophy ■ Deep brain stimulation for drug-resistant seizures in children ■ Catastrophic antiphospholipid antibody syndrome in children with strokes ■ Genetic epilepsies in children ■ Acute necrotizing encephalitis in children Basic science research Makram Obeid, MD , is involved in a research study investigating the efficacy of TAK242, a TLR4 blocker, against epileptogenesis and cognitive decline following traumatic hemorrhage in a novel repeated closed-head injury model.
Premier programs
TOP DISTINCTIONS
Neuromuscular Center Comprehensive
Comprehensive Epilepsy Program Only Level 4 Pediatric Epilepsy Center in Indiana; offers leading- edge diagnostic modalities, including MEG, and the most advanced medical and surgical treatment options such as laser ablation, surgical resection, neuromodulation and personalized treatment based on genetic testing.
■ Accredited by the National Association of Epilepsy Centers as a Level 4 epilepsy center (only such accredited center in Indiana) ■ Muscular Dystrophy Association Care Center, recognizing clinical care and research; Parent Project Muscular Dystrophy Certified Duchenne Care Center ■ One of the few centers in the nation performing gene therapy for Duchenne muscular dystrophy and spinal muscular atrophy ■ One of the few centers in the Midwest to offer magnetoencephalography (MEG) ■ Member of a unique clinical program for patients with Pelizaeus-Merzbacher disease; clinic held yearly for patients from across the U.S. ■ Pompe disease program offering genetics and physical therapy In 2026 Riley Neurology launched a Neuroimmunology Program to treat patients with autoimmune conditions such as autoimmune encephalitis, multiple sclerosis and myelin oligodendrocyte glycoprotein- associated disorders.
multidisciplinary program for patients with neuromuscular disorders; provides care coordination and leading-edge therapies, including gene therapy for a wide variety of genetic neuromuscular conditions.
Riley Children’s is a member of the Pediatric Epilepsy Research Consortium , a collaboration of more than 90 leading pediatric epilepsy programs nationwide.
NeuroNICU Program Indiana’s only neonatal
neurocritical care program; follows infants from the NICU to age 3, with diagnoses that include hypoxic- ischemic encephalopathy, intraventricular hemorrhage of prematurity, neonatal seizures, hydrocephalus, neonatal stroke, brain malformations and hypotonia; also an integral part of the Fetal Center . Pediatric Headache Center Multispecialty program dedicated to the diagnosis and longitudinal care of patients with complex and refractory headache disorders; offers botulinum toxin, nerve blocks and next-generation therapies; active in leading-edge research involving novel therapies and their use in pediatrics.
The EEG laboratory and the long-term EEG monitoring program at Riley Children’s are accredited by ABRET
Neurodiagnostic Credentialing and Accreditation.
NOTABLE PUBLICATIONS
Neuroscience Letters: November 2025 Short-term effects of sertraline against depressive-like behaviors in a rat model of neonatal hypoxic encephalopathy Epilepsy and Behavior: October 2025 Evaluating the documentation of the transition of care process for adolescents with epilepsy: Insights from a pediatric neurology clinic Pediatric Neurology: April 2025 Folic acid prescribing and reproductive counseling practices of
Novel procedures and advanced technologies ■ Increased use of MEG as new standard in evaluation for epilepsy surgery ■ Clinical trials of gene therapy for Duchenne muscular dystrophy and next-generation therapy for spinal muscular atrophy
DIVISION CHIEF Christopher T. Jackman, MD Associate Professor of Clinical Neurology, IU School of Medicine > Connect with Dr. Jackman on Doximity.
child neurologists for women with epilepsy Neurology Clinical Practice: February 2025
Spinal muscular atrophy update in best practices: Recommendations for treatment considerations Advances in Neonatal Care: April 2025 Impact of a sedation reduction protocol in infants undergoing MRI scanning
18 board certified physicians
See full team member list >
Refer a patient online
T 317.948.7450
Made with FlippingBook flipbook maker